Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether perioperative glutamine administration possess protective properties on internal organs (heart and gut) in patients with coronary atherosclerosis, operated under cardiopulmonary bypass.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Meshalkin Research Institute of Pathology of Circulation

Criteria

Inclusion Criteria:

• Adult patients with coronary artery disease operated on under cardiopulmonary bypass

Exclusion Criteria:

• Ejection fraction<40%

• Viral hepatitis

• Liver cirrhosis

• Cholecystitis

• Pancreatitis

• Chronic severe gastrointestinal disease

• Surgery on gastrointestinal tract in patient's medical history